Claims
- 1. A compound of the formula ##STR83## in which R.sup.1 is alkyl of 2 to 5 carbon atoms, allyl, benzyl, furylmethyl, wherein the furan ring is unsubstituted or substituted by bromine, or thienylmethyl, wherein the thiophene ring is unsubstituted or monosubstituted by methyl, and R.sup.2 is hydrogen, or
- R.sup.1 and R.sup.2 together with the nitrogen are a pyrrolidine ring,
- R.sup.3 is hydrogen, methyl or ethyl,
- R.sup.4 and R.sup.5 are hydrogen or R.sup.4 is methyl or ethyl in the .alpha.-position of the pyrrole ring and R.sup.5 is methyl, ethyl or n-propyl in the .alpha.'-position of the pyrrole ring,
- X is sulfur or oxygen, or N-H and
- Ar is phenyl, which is unsubstituted or substituted by chlorine
- and its therapeutically useful ammonium salts, alkali metal salts or acid addition salts.
- 2. A compound of the formula 1 as claimed in claim 1, in which
- R.sup.1 is n-butyl, benzyl, 3-thienylmethyl, 2-thienylmethyl, 3-furylmethyl or 2-furylmethyl,
- R.sup.2 is hydrogen,
- R.sup.3 is hydrogen,
- R.sup.4 is methyl or ethyl in the .alpha.-position to the nitrogen atom of the pyrrole ring,
- R.sup.5 is methyl, ethyl or n-propyl in the .alpha.'-position to the nitrogen atom in the pyrrole ring,
- X is sulfur, oxygen or N-H and
- Ar is phenyl,
- and its therapeutically useful ammonium salts and alkali metal salts.
- 3. A compound of the formula ##STR84## in which R.sup.1 is thienylmethyl, wherein the thiophene ring is unsubstituted or monosubstituted or disubstituted by chlorine,
- R.sup.2 is hydrogen,
- R.sup.3 is hydrogen, methyl or ethyl,
- R.sup.4 and R.sup.5 are hydrogen or R.sup.4 is methyl or ethyl in the .alpha.-position of the pyrrole ring and R.sup.5 is methyl, ethyl or n-propyl in the .alpha.'-position of the pyrrole ring,
- X is sulfur or oxygen, or N-H and
- Ar is phenyl, which is unsubstituted or substituted by chlorine
- and its therapeutically useful ammonium salts, alkali metal salts or acid addition salts.
- 4. A compound of the formula 3 as claimed in claim 1, in which R.sup.1 is 3-thienylmethyl, R.sup.2 to R.sup.5 are hydrogen, X is oxygen and Ar is phenyl.
- 5. A compound of the formula 3 as claimed in claim 1, in which R.sup.1 is 3-thienylmethyl, R.sup.2 and R.sup.3 are hydrogen, R.sup.4 and R.sup.5 are .alpha.-ethyl, X is oxygen and Ar is phenyl.
- 6. A compound of the formula 3 as claimed in claim 1, in which R.sup.1 is 3-thienylmethyl, R.sup.2 and R.sup.3 are hydrogen, R.sup.4 and R.sup.5 are .alpha.-methyl, X is NH and Ar is phenyl.
- 7. A compound of the formula 3 as claimed in claim 1, in which R.sup.1 is 2-thienylmethyl, R.sup.2 and R.sup.3 are hydrogen, R.sup.4 and R.sup.5 are .alpha.-methyl, X is oxygen and Ar is phenyl.
- 8. A compound of the formula 1 in claim 3 where R.sup.1 is 3-thienylmethyl, R.sup.2 and R.sup.3 are hydrogen, R.sup.4 is .alpha.-methyl, R.sup.5 is .alpha.'-ethyl, X is oxygen and Ar is phenyl.
- 9. A pharmaceutical diuretic composition comprising an effective amount of a compound of the formula I of claim 1 and a pharmaceutically acceptable carrier.
Priority Claims (2)
Number |
Date |
Country |
Kind |
2831850 |
Jul 1978 |
DEX |
|
2914615 |
Apr 1979 |
DEX |
|
Parent Case Info
This is a continuation of application Ser. No. 58,257, filed July 17, 1979, now abandoned.
US Referenced Citations (4)
Non-Patent Literature Citations (2)
Entry |
M. L. Hoefle et al., J. Med. Chem., 11 (1968), 970 et seq. |
W. Liebenow et al, Arzneim.-Forsch., (1975), 240 et seq. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
58257 |
Jul 1979 |
|